‘Revolutionary’ research discovers new cause of cancer comes from inside us
Australian cancer researchers have made an important new connection between a person’s cancer risk and…
Browsing: Featured
ASCO 2023: New drug combination twice as effective for some ovarian cancer patients as next best treatment
A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as…
Hydrogen sulfide-releasing treatment may improve cancer therapy
Hydrogen sulfide is usually a highly toxic gas. However, with careful preparation, it can be…
ASCO 2023: Axi-cel improves survival in early large B-cell lymphoma
Patients with early relapsed or refractory large B-cell lymphoma had significantly improved overall survival when treated with the chimeric…
ASCO 2023: Radiotherapy may not be necessary after chemoimmunotherapy for primary mediastinal B-cell lymphoma
Results from the largest prospective study of primary mediastinal B-cell lymphoma show that radiation therapy…
ASCO 2023: Multi-cancer blood test shows real promise
The SYMPLIFY study is the first large-scale evaluation of a multi-cancer early detection (MCED) test in individuals…
ASCO 2023: Study may provide clues to treating colorectal cancer more effectively in younger patients
While the incidence of colorectal cancer (CRC) has dropped significantly among older adults in recent…
ASCO 2023: Phase 3 trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy
A phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma…
ASCO 2023: Thyroid cancer precision approaches that incorporate targeted therapies and other treatments are changing the surgeon’s role
Historically, surgery was the first line of treatment for patients with thyroid cancer. Now, as…
ASCO 2023: Immunotherapy for brain cancer metastases shows clinical benefit
In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that…